Viewing Study NCT01676818


Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2026-05-31 @ 6:55 PM
Study NCT ID: NCT01676818
Status: COMPLETED
Last Update Posted: 2025-11-06
First Post: 2012-08-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Cervical Cancer View
None Stage IIIA Cervical Cancer View
None Stage IIIB Cervical Cancer View
None Stage IVA Cervical Cancer View
None Stage IVB Cervical Cancer View
Keywords: